NLRP3 and type 2 diabetes mellitus: In summary, CLANmCas9/gNLRP3-mediated NLRP3 knockout can improve the glucose tolerance and insulin sensitivity of HFD-induced T2D and ameliorate the inflammation of adipose tissue through inhibition of NLRP3 inflammasome activation.